Kahira Pharmaceuticals & Chemical Industries Company

CASE:CPCI Stock Report

Market Cap: ج.م986.9m

Kahira Pharmaceuticals & Chemical Industries Past Earnings Performance

Past criteria checks 5/6

Kahira Pharmaceuticals & Chemical Industries has been growing earnings at an average annual rate of 11.5%, while the Pharmaceuticals industry saw earnings growing at 11.5% annually. Revenues have been growing at an average rate of 3.7% per year. Kahira Pharmaceuticals & Chemical Industries's return on equity is 30%, and it has net margins of 17.1%.

Key information

11.5%

Earnings growth rate

5.2%

EPS growth rate

Pharmaceuticals Industry Growth9.8%
Revenue growth rate3.7%
Return on equity30.0%
Net Margin17.1%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Kahira Pharmaceuticals & Chemical Industries makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CASE:CPCI Revenue, expenses and earnings (EGP Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 241,3852361080
30 Sep 231,0881171050
30 Jun 231,005971040
31 Mar 2391171-620
30 Sep 221,1051681060
30 Jun 221,1121661020
31 Mar 221,1201721000
31 Dec 211,057139950
30 Sep 211,033127890
30 Jun 211,062124880
31 Mar 211,042120980
31 Dec 201,028119970
30 Sep 201,0491171010
30 Jun 201,010109990
31 Mar 209991051030
31 Dec 19972981040
30 Sep 19950801080
30 Jun 19963851080
31 Mar 199831011010
31 Dec 189631001000
30 Sep 18925113970
30 Jun 18863108950
31 Mar 188011051180
31 Dec 17747991080
30 Sep 1772198950
30 Jun 1769088860
31 Mar 1764074420
31 Dec 1659858430
30 Sep 1656249430
30 Jun 1651742420
31 Mar 1650045430
31 Dec 1549148410
30 Sep 1546545390
30 Jun 1545143400
31 Mar 1543934370
31 Dec 1443137370
30 Sep 1441537380
30 Jun 1440441360
31 Mar 1440457350
31 Dec 1339659340
30 Sep 1338758320
30 Jun 1337554320

Quality Earnings: CPCI has a high level of non-cash earnings.

Growing Profit Margin: CPCI's current net profit margins (17.1%) are higher than last year (7.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CPCI's earnings have grown by 11.5% per year over the past 5 years.

Accelerating Growth: CPCI's earnings growth over the past year (233.7%) exceeds its 5-year average (11.5% per year).

Earnings vs Industry: CPCI earnings growth over the past year (233.7%) exceeded the Pharmaceuticals industry 51.8%.


Return on Equity

High ROE: CPCI's Return on Equity (30%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.